Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now
Corporate Profile

Investor Presentation

Read Now


Our Pipeline

Learn More
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

November 6, 2019

BeiGene Announces Clinical Data on Zanubrutinib to Be Presented at the 61st American Society of Hematology Annual Meeting

November 5, 2019

Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate

October 31, 2019

BeiGene Announces Global Strategic Oncology Collaboration with Amgen

Key Metrics

Key Metrics

  • 2,700


  • 1,000+

    Clinical team

  • 4


This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.